Total Payments
$1,282
2024 Payments
$17.02
Companies
25
Transactions
86
Medicare Patients
571
Medicare Billing
$42,669
Payment Breakdown by Category
Food & Beverage$1,134 (88.5%)
Education$147.78 (11.5%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $1,134 | 69 | 88.5% |
| Education | $147.78 | 17 | 11.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| PFIZER INC. | $229.95 | 24 | $0 (2019) |
| Salix Pharmaceuticals, a division of Bausch Health US, LLC | $159.08 | 11 | $0 (2018) |
| Allergan Inc. | $152.82 | 8 | $0 (2017) |
| Merck Sharp & Dohme Corporation | $136.79 | 8 | $0 (2019) |
| Astellas Pharma US Inc | $80.74 | 4 | $0 (2019) |
| Genentech USA, Inc. | $64.91 | 3 | $0 (2019) |
| Janssen Biotech, Inc. | $48.44 | 3 | $0 (2019) |
| SANOFI-AVENTIS U.S. LLC | $40.61 | 2 | $0 (2017) |
| Amgen Inc. | $36.61 | 2 | $0 (2019) |
| Valeant Pharmaceuticals North America LLC | $34.66 | 2 | $0 (2017) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $17.02 | 1 | Regeneron Healthcare Solutions, Inc. ($17.02) |
| 2022 | $11.97 | 1 | Acrotech Biopharma LLC ($11.97) |
| 2021 | $13.93 | 1 | Acrotech Biopharma LLC ($13.93) |
| 2019 | $434.11 | 32 | PFIZER INC. ($123.97) |
| 2018 | $484.23 | 34 | Salix Pharmaceuticals, a division of Bausch Health US, LLC ($159.08) |
| 2017 | $320.25 | 17 | Allergan Inc. ($152.82) |
All Payment Transactions
86 individual payment records from CMS Open Payments — Page 1 of 4
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 08/23/2024 | Regeneron Healthcare Solutions, Inc. | LIBTAYO (Biological) | Education | In-kind items and services | $17.02 | General |
| Category: ONCOLOGY | ||||||
| 03/29/2022 | Acrotech Biopharma LLC | BELEODAQ (Drug) | Education | In-kind items and services | $11.97 | General |
| Category: ONCOLOGY | ||||||
| 10/11/2021 | Acrotech Biopharma LLC | BELEODAQ (Drug) | Education | In-kind items and services | $13.93 | General |
| Category: ONCOLOGY | ||||||
| 10/31/2019 | PFIZER INC. | BOSULIF (Drug) | Education | In-kind items and services | $8.12 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 10/10/2019 | PFIZER INC. | BOSULIF (Drug) | Education | In-kind items and services | $8.12 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 10/09/2019 | Sirtex Medical Inc | SIR-Spheres Microspheres (Device) | Food and Beverage | Cash or cash equivalent | $14.08 | General |
| Category: Interventional Oncology | ||||||
| 09/06/2019 | PFIZER INC. | BOSULIF (Drug) | Education | In-kind items and services | $8.12 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 08/29/2019 | PFIZER INC. | BOSULIF (Drug) | Education | In-kind items and services | $8.12 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 08/01/2019 | Janssen Pharmaceuticals, Inc | XARELTO (Drug) | Food and Beverage | In-kind items and services | $18.74 | General |
| Category: Cardiovascular & Metabolism | ||||||
| 07/30/2019 | Genentech USA, Inc. | TECENTRIQ (Biological) | Food and Beverage | In-kind items and services | $22.27 | General |
| Category: BioOncology | ||||||
| 07/25/2019 | Janssen Biotech, Inc. | Erleada (Drug) | Food and Beverage | In-kind items and services | $14.75 | General |
| Category: Oncology | ||||||
| 07/25/2019 | PFIZER INC. | BOSULIF (Drug) | Education | In-kind items and services | $8.12 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 07/18/2019 | Alexion Pharmaceuticals, Inc. | — | Food and Beverage | In-kind items and services | $32.30 | General |
| 07/16/2019 | Amgen Inc. | Kyprolis (Biological) | Food and Beverage | In-kind items and services | $16.79 | General |
| Category: Oncology | ||||||
| 07/12/2019 | TerSera Therapeutics LLC | VARUBI (Drug) | Food and Beverage | In-kind items and services | $16.99 | General |
| Category: ONCOLOGY | ||||||
| 07/11/2019 | Merck Sharp & Dohme Corporation | KEYTRUDA (Biological) | Food and Beverage | In-kind items and services | $19.63 | General |
| Category: ONCOLOGY | ||||||
| 06/27/2019 | Lilly USA, LLC | ALIMTA (Drug), CYRAMZA, VERZENIO | Food and Beverage | In-kind items and services | $11.76 | General |
| Category: Oncology | ||||||
| 06/18/2019 | PFIZER INC. | DAURISMO (Drug) | Education | In-kind items and services | $10.70 | General |
| Category: ONCOLOGY | ||||||
| 06/18/2019 | PFIZER INC. | BOSULIF (Drug) | Education | In-kind items and services | $8.12 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 06/17/2019 | PFIZER INC. | BOSULIF (Drug) | Food and Beverage | In-kind items and services | $10.38 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 05/31/2019 | PFIZER INC. | DAURISMO (Drug) | Education | In-kind items and services | $10.70 | General |
| Category: ONCOLOGY | ||||||
| 05/31/2019 | PFIZER INC. | BOSULIF (Drug) | Education | In-kind items and services | $8.12 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
| 05/08/2019 | E.R. Squibb & Sons, L.L.C. | EMPLICITI (Biological) | Food and Beverage | Cash or cash equivalent | $10.81 | General |
| Category: Oncology | ||||||
| 05/01/2019 | Exelixis Inc. | Cabometyx (Drug) | Food and Beverage | In-kind items and services | $14.18 | General |
| Category: Oncology | ||||||
| 04/16/2019 | PFIZER INC. | BOSULIF (Drug) | Education | In-kind items and services | $8.12 | General |
| Category: METABOLIC DISEASE;ONCOLOGY | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 128 | 212 | $34,304 | $11,895 |
| 2022 | 3 | 94 | 148 | $24,746 | $9,003 |
| 2021 | 3 | 121 | 191 | $29,051 | $11,030 |
| 2020 | 5 | 228 | 314 | $30,030 | $10,740 |
Total Patients
571
Total Services
865
Medicare Billing
$42,669
Procedure Codes
15
All Medicare Procedures & Services
15 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 41 | 95 | $18,473 | $6,457 | 35.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 62 | 73 | $9,612 | $3,054 | 31.8% |
| 99231 | Subsequent hospital care with straightforward or low level of medical decision making, per day, if using time, at least 25 minutes | Facility | 2023 | 13 | 32 | $3,063 | $1,265 | 41.3% |
| 99222 | Initial hospital care with straightforward or low-level medical decision making, if using time, at least 55 minutes | Facility | 2023 | 12 | 12 | $3,157 | $1,119 | 35.5% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2022 | 25 | 56 | $10,998 | $4,096 | 37.2% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2022 | 58 | 81 | $10,792 | $3,936 | 36.5% |
| 99204 | New patient office or other outpatient visit, 45-59 minutes | Office | 2022 | 11 | 11 | $2,956 | $971.67 | 32.9% |
| 99214 | Established patient outpatient visit, total time 30-39 minutes | Office | 2021 | 35 | 78 | $15,313 | $6,113 | 39.9% |
| 99213 | Established patient outpatient visit, total time 20-29 minutes | Office | 2021 | 69 | 95 | $12,648 | $4,569 | 36.1% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2021 | 17 | 18 | $1,090 | $348.60 | 32.0% |
| 99213 | Established patient office or other outpatient visit, typically 15 minutes | Office | 2020 | 77 | 114 | $11,721 | $3,871 | 33.0% |
| 99441 | Physician telephone patient service, 5-10 minutes of medical discussion | Office | 2020 | 86 | 117 | $5,535 | $2,347 | 42.4% |
| 99214 | Established patient office or other outpatient, visit typically 25 minutes | Office | 2020 | 28 | 40 | $6,347 | $1,987 | 31.3% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 12 | 12 | $3,307 | $1,341 | 40.5% |
| 99442 | Physician telephone patient service, 11-20 minutes of medical discussion | Office | 2020 | 25 | 31 | $3,119 | $1,195 | 38.3% |
About Dr. Muhammad Isa, M.D
Dr. Muhammad Isa, M.D is a Hematology & Oncology healthcare provider based in Fort Worth, Texas. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 07/26/2006. The National Provider Identifier (NPI) number assigned to this provider is 1548284342.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Muhammad Isa, M.D has received a total of $1,282 in payments from pharmaceutical and medical device companies, with $17.02 received in 2024. These payments were reported across 86 transactions from 25 companies. The most common payment nature is "Food and Beverage" ($1,134).
As a Medicare-enrolled provider, Isa has provided services to 571 Medicare beneficiaries, totaling 865 services with total Medicare billing of $42,669. Data is available for 4 years (2020–2023), covering 15 distinct procedure/service records.
Ad
Practice Information
- Specialty Hematology & Oncology
- Other Specialties Medical Oncology
- Location Fort Worth, TX
- Active Since 07/26/2006
- Last Updated 07/27/2018
- Taxonomy Code 207RH0003X
- Entity Type Individual
- NPI Number 1548284342
Products in Payments
- RELISTOR (Drug) $120.53
- AVYCAZ (Drug) $111.74
- BOSULIF (Drug) $105.29
- Erleada (Drug) $48.44
- KEYTRUDA (Biological) $48.11
- TECENTRIQ (Biological) $47.18
- XIFAXAN (Drug) $43.35
- DALVANCE (Drug) $41.08
- LANTUS (Drug) $40.61
- ISENTRESS (Drug) $37.75
- CHANTIX (Drug) $37.16
- Kyprolis (Biological) $36.61
- Abraxane (Drug) $31.63
- XIFIXAN (Drug) $29.86
- Baxdela (Drug) $28.58
- Cabometyx (Drug) $26.02
- BELEODAQ (Drug) $25.90
- Cresemba (Drug) $24.86
- Lexiscan (Drug) $22.93
- DAURISMO (Drug) $21.40
Explore
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Hematology & Oncology Doctors in Fort Worth
Dr. Prasanthi Ganesa, M.d, M.D
Hematology & Oncology — Payments: $225,864
Hematology & Oncology $225,864
Robyn Young, M.d, M.D
Hematology & Oncology — Payments: $145,466
Hematology & Oncology $145,466
Henry Xiong, M.d, M.D
Hematology & Oncology — Payments: $133,941
Hematology & Oncology $133,941
Harris Naina, Md, MD
Hematology & Oncology — Payments: $100,947
Hematology & Oncology $100,947
Asim Ahmad, Md, MD
Hematology & Oncology — Payments: $84,824
Hematology & Oncology $84,824
Timothy Mccavit, Md, MD
Hematology & Oncology — Payments: $48,338
Hematology & Oncology $48,338